Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.
CANCELLED - Design Your Novel Polymers & Maximize Payload Compatibility for Sustained & Controlled Release
In recent months we have seen Genentech sign a non-viral polymeric nanoparticle deal worth up to $644m with GenEdit, improving efforts to deliver gene therapies for autoimmune diseases. Additionally, Bioorchestra signed a $861m pact to advance CNS targeted polymeric nanoparticle production , as well as Nanite investing $2m in the Cystic Fibrosis Foundation to develop polymer gene delivery technologies for the lung.
The time is now to combine forces and continue to drive polymeric drug delivery into the limelight, driving life-changing therapies to the previously undruggable!
The Polymer Chemistry & Formulation in Drug Delivery Summit is the first meeting of its kind to address the specific advancements and technical challenges of polymer-based delivery systems to enable potent delivery of your given payload across a wide variety of disease indications.
Join 60+ polymer chemistry, engineering, characterization and delivery experts this May to ensure your polymer delivery systems are optimized for maximum therapeutic impact. With the convergence of cutting-edge research and industry pioneers, this summit provides a unique platform to exchange insights, foster collaborations, and chart the course for the future of polymer-based drug delivery.